Advertisement

Ads Placeholder
Loading...

Arcellx, Inc.

ACLXNASDAQ
Healthcare
Biotechnology
$114.77
$0.02(0.02%)
U.S. Market opens in 32h 26m

Arcellx, Inc. (ACLX) Stock Overview

Explore Arcellx, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap6.7B
P/E Ratio-28.23
EPS (TTM)$-4.07
ROE-0.55%
Fundamental Analysis

AI Price Forecasts

1 Month$114.17
3 Months$61.62
1 Year Target$95.74

ACLX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Arcellx, Inc. (ACLX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 82.29, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $95.74.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -28.23 and a market capitalization of 6.7B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.02%
5-Day Change
0.13%
1-Month Change
0.63%
3-Month Change
81.20%
6-Month Change
34.91%
Year-to-Date (YTD) Change
81.20%
1-Year Change
83.81%
3-Year Change
290.77%
5-Year Change
583.15%
All-Time (Max) Change
583.15%

Contact Information

240 327 0603
25 West Watkins Mill Road, Redwood City, MD, 20878

Company Facts

1,630 Employees
IPO DateFeb 4, 2022
CountryUS
Actively Trading

Frequently Asked Questions